This contract expires in 192 days (Jan 16, 2027).
JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. - IOFLUPANE - BRAND NAME OR EQUAL
Key Details
Description
IOFLUPANE - BRAND NAME OR EQUAL
Context & Analysis
On Jan 15, 2026, Department of Veterans Affairs obligated $132,000 to JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. for ioflupane - brand name or equal. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PHILADELPHIA, PA. The contract is scheduled through Jan 16, 2027 — approximately 6 months remaining. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.